d‐Sorbose Promotes Regulatory T‐Cell Differentiation and Ameliorates Autoimmune and Allergic Diseases via Hexosamine Biosynthetic Pathway Inhibition
The FASEB Journal · 15.09.2026 · 40 (17)
DOI: 10.1096/fj.202601110r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 28.08.2026. Verfasst von Fumiaki Sato und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Disease Systems Analysis Medicine, Fujita Health University School of Medical Sciences, Toyoake, Aichi, Japan. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Cell Differentiation, Hexosamines, Diabetes Mellitus, Type 1. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS), Fujita Health University, Matsutani Chemical Industry Co., Ltd..
Abstract (Originalsprache)
Monosaccharides are fundamental biomolecules involved in various biological processes. Rare sugars, naturally scarce monosaccharide derivatives, exhibit unique physiological effects independent of standard energy metabolism. Among them, d‐sorbose, the C‐3 epimer of d‐fructose, has poorly understood biological functions. This study investigated the immunometabolic effects of d‐sorbose, focusing on regulatory T‐cell (Treg) differentiation and immune modulation. Ex vivo assays using splenic naïve CD4 + T cells revealed that d‐sorbose significantly increased Foxp3 + Treg frequencies to levels comparable to d‐mannose, without inducing the CD8 + T cell reduction observed with d‐mannose. In vivo, continuous d‐sorbose administration ameliorated ovalbumin‐induced airway inflammation and prevented autoimmune diabetes in non‐obese diabetic mice by selectively increasing interleukin‐10‐producing Tregs in regional lymph nodes and inflamed tissues. Histological analyses revealed reduced inflammatory cell infiltration and preserved tissue architecture in d‐sorbose‐treated groups. Metabolomic profiling indicated that d‐sorbose suppressed glycolysis, the pentose phosphate pathway, and the hexosamine biosynthetic pathway (HBP), as evidenced by decreased UDP‐GlcNAc levels, while elevating the tricarboxylic acid cycle intermediate malate. Pharmacological inhibition of glutamine–fructose‐6‐phosphate aminotransferase, combined with glutamine restriction and GlcNAc rescue assays, demonstrated that d‐sorbose promotes Treg differentiation through coordinated metabolic reprogramming of glucose partitioning and glutamine catabolism rather than passive HBP inhibition. Notably, d‐sorbose treatment did not alter T‐cell survival and demonstrated a favorable safety profile during long‐term administration. These findings identify d‐sorbose as a novel immunoregulatory sugar that promotes functional Treg differentiation by orchestrating intracellular glucose and glutamine metabolism, highlighting its potential as a dietary or therapeutic agent for controlling inflammatory and autoimmune diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Disease Systems Analysis Medicine, Fujita Health University School of Medical Sciences, Toyoake, Aichi, Japan.
- Department of Medical Science Technology, School of Health Science at Narita, International University of Health and Welfare, Narita, Chiba, Japan.
- Department of Medical Technology, Gifu University of Medical Science, Seki, Gifu, Japan.
- Research and Development, Matsutani Chemical Industry Co. Ltd., Itami, Hyogo, Japan.
- Department of Cellular Function Analysis, Research Promotion Headquarters, Fujita Health University, Toyoake, Aichi, Japan.
- Department of Joint Research Laboratory of Clinical Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
ORCID-Profile: Fumiaki Sato, Masato Hoshi, Hiroyuki Yokoi, Sayaka Yoshida, Ryosuke Takenaka, Nao Shimoga, Nanaka Morita, Chieko Tashita, Kyoka Yamazaki, Yuka Kishimoto, Hiroyuki Tezuka, Hiroyasu Ito, Kuniaki Saito
Förderung
- MEXT | Japan Society for the Promotion of Science (JSPS)
- Fujita Health University
- Matsutani Chemical Industry Co., Ltd.
Zitieren
APA
Sato, F., Hoshi, M., Yokoi, H., Yoshida, S., Takenaka, R., Shimoga, N., Morita, N., Tashita, C., Yamazaki, K., Kishimoto, Y., Tezuka, H., Ito, H., & Saito, K. (2026). d‐Sorbose Promotes Regulatory T‐Cell Differentiation and Ameliorates Autoimmune and Allergic Diseases via Hexosamine Biosynthetic Pathway Inhibition. The FASEB Journal, 40(17). https://doi.org/10.1096/fj.202601110r
Vancouver
Sato F, Hoshi M, Yokoi H, Yoshida S, Takenaka R, Shimoga N, et al. d‐Sorbose Promotes Regulatory T‐Cell Differentiation and Ameliorates Autoimmune and Allergic Diseases via Hexosamine Biosynthetic Pathway Inhibition. The FASEB Journal. 2026;40(17). doi:10.1096/fj.202601110r
BibTeX
@article{Sato2026,
author = {Sato, Fumiaki and Hoshi, Masato and Yokoi, Hiroyuki and Yoshida, Sayaka and Takenaka, Ryosuke and Shimoga, Nao and Morita, Nanaka and Tashita, Chieko and Yamazaki, Kyoka and Kishimoto, Yuka and Tezuka, Hiroyuki and Ito, Hiroyasu and Saito, Kuniaki},
title = {d‐Sorbose Promotes Regulatory T‐Cell Differentiation and Ameliorates Autoimmune and Allergic Diseases via Hexosamine Biosynthetic Pathway Inhibition},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {17},
doi = {10.1096/fj.202601110r}
}
EUVIMED